CYB004
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CYB004, covering 2025-10-27 to 2025-10-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD) [Phase 2]